Viewing StudyNCT04541589



Ignite Creation Date: 2024-05-06 @ 3:10 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04541589
Status: COMPLETED
Last Update Posted: 2024-07-12
First Post: 2020-08-14

Brief Title: Study of Safety and Tolerability of CFZ533 in Patients With Sjögrens Syndrome
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Sjogrens Syndrome
Keywords:
Name View
TWINSS Extension View
Sjogrens Syndrome View
autoimmune View
ESSDAI View
ESSPRI View
anti-CD40 View
CFZ533 View
iscalimab View